Viewing StudyNCT00291967



Ignite Creation Date: 2024-05-05 @ 4:41 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00291967
Status: COMPLETED
Last Update Posted: 2006-12-08
First Post: 2006-02-14

Brief Title: Assess Immune Response Following Primary Vaccination With Tritanrix-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neisseria Meningitidis Serogroups A C Diseases
Diphtheria
Tetanus
Pertussis
Hepatitis B
Hib Diseases
Keywords: